Artificial Blood Cells Market Report Opportunities, and Forecast By 2033

(0 User reviews)   96   56
By Eric Martin Posted on Oct 9, 2023
In Category - Business
Manjeet Ahirwar
Abstract
According to the Market Statsville Group (MSG), the Global Artificial Blood Cells Market size is expected to grow from USD 20.5 million in 2023 to USD 120.0 million by 2033, at a CAGR of 19.3% from 2023 to 2033. The persistent shortage of donor blood for transfusions has created a pressing need for alternative solutions. Artificial blood cells offer a reliable and scalable means to supplement existing blood supplies, particularly in emergencies or regions with limited access to safe donor blood. This demand stems from the urgent requirement to ensure an adequate and timely response to traumatic injuries, surgeries, and medical procedures. The advancements in nanotechnology and biomaterials have paved the way for creating artificial blood cells with enhanced properties. These engineered constructs can exhibit prolonged circulation times, improved oxygen-carrying capacities, and reduced risks of immune reactions, making them attractive candidates for clinical use. As these technologies continue to mature, the demand for more efficient and safer blood substitutes is expected to rise.
Artificial Blood Cells Market

According to the Market Statsville Group (MSG), the Global Artificial Blood Cells Market size is expected to grow from USD 20.5 million in 2023 to USD 120.0 million by 2033, at a CAGR of 19.3% from 2023 to 2033. The persistent shortage of donor blood for transfusions has created a pressing need for alternative solutions. Artificial blood cells offer a reliable and scalable means to supplement existing blood supplies, particularly in emergencies or regions with limited access to safe donor blood. This demand stems from the urgent requirement to ensure an adequate and timely response to traumatic injuries, surgeries, and medical procedures. The advancements in nanotechnology and biomaterials have paved the way for creating artificial blood cells with enhanced properties. These engineered constructs can exhibit prolonged circulation times, improved oxygen-carrying capacities, and reduced risks of immune reactions, making them attractive candidates for clinical use. As these technologies continue to mature, the demand for more efficient and safer blood substitutes is expected to rise.

There are no reviews for this Book.

0
0 out of 5 (0 User reviews )

Add a Review

Your Rating *
There are no comments for this Book.
You must log in to post a comment.
Log in

Related Books